12/12
08:06 am
cytk
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $72.00 price target on the stock.
Medium
Report
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $72.00 price target on the stock.
12/12
05:55 am
cytk
Rating for CYTK
Medium
Report
Rating for CYTK
12/12
05:55 am
cytk
Rating for CYTK
Medium
Report
Rating for CYTK
12/1
11:06 am
cytk
Cytokinetics (NASDAQ:CYTK) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Cytokinetics (NASDAQ:CYTK) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
11/11
10:20 am
cytk
Rating for CYTK
Medium
Report
Rating for CYTK
11/11
10:20 am
cytk
Rating for CYTK
Medium
Report
Rating for CYTK
11/10
10:04 am
cytk
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at B. Riley. They now have a $90.00 price target on the stock, up previously from $80.00.
Low
Report
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at B. Riley. They now have a $90.00 price target on the stock, up previously from $80.00.
11/10
10:04 am
cytk
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at B. Riley. They now have a $90.00 price target on the stock, up previously from $80.00.
Low
Report
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at B. Riley. They now have a $90.00 price target on the stock, up previously from $80.00.
10/21
08:04 am
cytk
Cytokinetics (NASDAQ:CYTK) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
Low
Report
Cytokinetics (NASDAQ:CYTK) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald.
10/6
08:59 am
cytk
Rating for CYTK
Medium
Report
Rating for CYTK
10/6
08:59 am
cytk
Rating for CYTK
Medium
Report
Rating for CYTK
9/29
12:28 pm
cytk
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
Low
Report
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
9/22
08:08 am
cytk
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.
Low
Report
Cytokinetics (NASDAQ:CYTK) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $120.00 price target on the stock.